Skip to main content
Clinical Trials/JPRN-UMIN000051879
JPRN-UMIN000051879
Not yet recruiting
未知

A multicenter prospective study to determine the optimal range of lymph node dissection in pancreatic cancer surgery after neoadjuvant chemotherapy(-Project study by the Japan Pancreas Society and JON 2302-P-) - LYMRIN trial

niversity of Toyama0 sites545 target enrollmentOctober 1, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Pancreatic invasive ductal adenocarcinoma
Sponsor
niversity of Toyama
Enrollment
545
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 1, 2023
End Date
October 30, 2031
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Toyama

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • \#Active synchronous cancers \#Severe complication \#Inability to safely perform protocol surgery \#Pretreatment other than protocol neoadjuvant chemotherapy \#Pregnant, lactating woman or possible pregnancy \#Psychiatric illness that interferes with daily life

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Multicenter study for outcomes of stabilization surgery in unstable shoulderHealth Condition 1: M244- Recurrent dislocation of joint
CTRI/2023/12/060688Dipit Sahu
Completed
Not Applicable
Pulmonary Hypertension in the Intensive Care Unit (ICU) - Swiss Survey 1
ISRCTN01751283Swiss Society of Pulmonary Hypertension (Switzerland)1,000
Completed
Not Applicable
Study of management of preterm labor in IndiaHealth Condition 1: null- Preterm Labor
CTRI/2017/04/008307Abbott India Limited285
Active, not recruiting
Phase 1
A clinical study to compare the effects of cadazolid with vancomycin in children with Clostridium difficile-associated diarrhea.
EUCTR2015-004805-17-BEActelion Pharmaceuticals Ltd.200
Active, not recruiting
Phase 1
A clinical study to compare the effects of cadazolid with vancomycin in children with Clostridium difficile-associated diarrhea.Clostridium difficile-associated diarrhea (CDAD)MedDRA version: 20.0Level: LLTClassification code 10012734Term: Diarrhea, Clostridium difficileSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0Level: PTClassification code 10054236Term: Clostridium difficile infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0Level: LLTClassification code 10022661Term: Intestinal infection due to clostridium difficileSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0Level: LLTClassification code 10012748Term: Diarrhoea, Clostridium difficileSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
EUCTR2015-004805-17-ESActelion Pharmaceuticals Ltd.1